Supplementary Data from Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Markus W. Löffler,Stefania Gori,Francesco Izzo,Andrea Mayer-Mokler,Paolo A. Ascierto,Alfred Königsrainer,Yuk Ting Ma,Bruno Sangro,Sven Francque,Luisa Vonghia,Alessandro Inno,Antonio Avallone,Jörg Ludwig, Diego Duarte Alcoba,Christian Flohr,Katrin Aslan,Regina Mendrzyk,Heiko Schuster,Marco Borrelli,Danila Valmori,Tanguy Chaumette,Regina Heidenreich,Cécile Gouttefangeas,Greta Forlani,Maria Tagliamonte,Caterina Fusco,Roberta Penta,Mercedes Iñarrairaegui,Ulrike Gnad-Vogt,Carsten Reinhardt,Toni Weinschenk,Roberto S. Accolla,Harpreet Singh-Jasuja,Hans-Georg Rammensee,Luigi Buonaguro openalex（2023）
Key words
Hepatocellular Carcinoma,Vaccine Adjuvants,Cancer Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper